Inogen (INGN) Liabilities and Shareholders Equity (2013 - 2026)

Inogen (INGN) has reported Liabilities and Shareholders Equity for 14 consecutive years, with $285.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 7.29% year-over-year to $285.9 million; the TTM figure through Mar 2026 stood at $1.2 billion (down 1.32% YoY), while the FY2025 annual figure was $298.6 million, up 0.82% from the prior year.
• Liabilities and Shareholders Equity retreated to $285.9 million in Q1 2026 per INGN's latest filing, from $298.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $474.6 million in Q1 2022 and bottomed at $285.9 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $352.2 million across 5 years, with a median of $315.6 million in 2024.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity decreased 26.81% — and 2025, when it gained 1.01%.
• Inogen's Liabilities and Shareholders Equity stood at $405.0 million in 2022, then decreased by 19.47% to $326.2 million in 2023, then dropped by 9.2% to $296.2 million in 2024, then climbed by 0.82% to $298.6 million in 2025, then slipped by 4.25% to $285.9 million in 2026.
• Business Quant data shows INGN's Liabilities and Shareholders Equity at $285.9 million in Q1 2026, $298.6 million in Q4 2025, and $307.0 million in Q3 2025.